HLA class II molecule HLA-DRA identifies immuno-hot tumors and predicts the therapeutic response to anti-PD-1 immunotherapy in NSCLCJie Mei, Junying Xu, Yundi Chen et al.|BMC Cancer|2022Cited by 35